Karina Lizzi-Ansok

Karina Lizzi-Ansok, MPH, MBA, currently serves as the Associate Director of Trial Feasibility & Site Identification at Daiichi Sankyo, Inc. since March 2024. Previously, Karina held roles at Pfizer, including Disease Intelligence Analytics Lead and Associate Director of Feasibility Lead in Oncology, where responsibilities included developing strategies for clinical programs and managing feasibility processes. Prior experience encompasses positions at PPD, Covance, Clinipace Worldwide, and Syneos Health, focusing on feasibility assessment, proposal management, and clinical research coordination. Karina's academic background includes an MBA from the University of Massachusetts Amherst, an MPH from the University of Miami Miller School of Medicine, and a BS in Science Pre-Professional from the University of Notre Dame.